Disclosure 0001193125-26-396890-2

SEC FORM 4

$7,129.09

Bolt Biotherapeutics, Inc. (BOLT)

Sale of 1,889 shares at $3.7740 per share.

Reporting Person Quinn William P. · Officer Title President, CEO and CFO · Transaction Code S

Traded Sep 16, 2026 · Disclosed Sep 21, 2026FILED +5 DAYS

Source: SEC Form 4 · 0001193125-26-396890 · filed 2026-09-21 · View filing →

Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?

Cite this card

Desq Long. "Bolt Biotherapeutics, Inc. (BOLT)." Disclosed 2026-09-21. https://desqlong.com/cards/0001193125-26-396890-2 (retrieved 2026-09-26).